Literature DB >> 16699639

Neurological disease in HIV-infected patients in the era of highly active antiretroviral treatment: a Brazilian experience.

Jacqueline Ferreira de Oliveira1, Dirceu Bartolomeu Greco, Guilherme Correa Oliveira, Paulo Pereira Christo, Mark Drew Crosland Guimarães, Rodrigo Corrêa Oliveira.   

Abstract

To study characteristics of neurological disorders in HIV/AIDS patients and their relationship to highly active antiretroviral treatment, a cross-sectional study was conducted in an infectious disease public hospital in Belo Horizonte, Brazil, between February 1999 and March 2000. Of the 417 patients enrolled, neurological disease was observed in 194 (46.5%) and a new AIDS-defining neurological event developed in 23.7% of individuals. Toxoplasmosis (42.3%), cryptococcosis meningitis (12.9%) and tuberculosis (10.8%) were the most common causes of neurological complications. The majority (79.3%) of patients were on highly active antiretroviral treatment and these individuals using HAART showed higher CD4 cell counts (p = 0.014) and presented stable neurological disease (p = 0.0001), although no difference was found with respect to the profile of neurological complications. The neurological diseases continue to be a frequent complication of HIV/AIDS and infections are still its main causes in Brazil, even in the highly active antiretroviral treatment era.

Entities:  

Mesh:

Year:  2006        PMID: 16699639     DOI: 10.1590/s0037-86822006000200002

Source DB:  PubMed          Journal:  Rev Soc Bras Med Trop        ISSN: 0037-8682            Impact factor:   1.581


  17 in total

1.  Biomarkers of HIV-1-associated neurocognitive disorders: challenges of proteomic approaches.

Authors:  Pawel Ciborowski
Journal:  Biomark Med       Date:  2009-12       Impact factor: 2.851

2.  Inhibition of Calcium Dependent Protein Kinase 1 (CDPK1) by Pyrazolopyrimidine Analogs Decreases Establishment and Reoccurrence of Central Nervous System Disease by Toxoplasma gondii.

Authors:  Florentine U Rutaganira; Jennifer Barks; Mary Savari Dhason; Qiuling Wang; Michael S Lopez; Shaojun Long; Joshua B Radke; Nathaniel G Jones; Amarendar R Maddirala; James W Janetka; Majida El Bakkouri; Raymond Hui; Kevan M Shokat; L David Sibley
Journal:  J Med Chem       Date:  2017-10-09       Impact factor: 7.446

3.  Role of quantitative CSF microscopy to predict culture status and outcome in HIV-associated cryptococcal meningitis in a Brazilian cohort.

Authors:  José E Vidal; Juliana Gerhardt; Erique J Peixoto de Miranda; Rafi F Dauar; Gilberto S Oliveira Filho; Augusto C Penalva de Oliveira; David R Boulware
Journal:  Diagn Microbiol Infect Dis       Date:  2012-05       Impact factor: 2.803

4.  Mortality trends from 2003 to 2009 among adolescents and young adults in rural Western Kenya using a health and demographic surveillance system.

Authors:  Penelope A Phillips-Howard; Frank O Odhiambo; Mary Hamel; Kubaje Adazu; Marta Ackers; Anne M van Eijk; Vincent Orimba; Anja van't Hoog; Caryl Beynon; John Vulule; Mark A Bellis; Laurence Slutsker; Kevin deCock; Robert Breiman; Kayla F Laserson
Journal:  PLoS One       Date:  2012-11-05       Impact factor: 3.240

5.  Neurological complications in late-stage hospitalized patients with HIV disease.

Authors:  Rakendra Singh; Manjot Kaur; Deepak Arora
Journal:  Ann Indian Acad Neurol       Date:  2011-07       Impact factor: 1.383

6.  Neuropathology of AIDS: An Autopsy Review of 284 Cases from Brazil Comparing the Findings Pre- and Post-HAART (Highly Active Antiretroviral Therapy) and Pre- and Postmortem Correlation.

Authors:  Ana Cristina Araújo Lemos Silva; Blenda Sousa Carli Rodrigues; Adilha Misson Rua Micheletti; Sebastião Tostes; Antonio Carlos Oliveira Meneses; Mário Leon Silva-Vergara; Sheila Jorge Adad
Journal:  AIDS Res Treat       Date:  2012-02-22

7.  HIV-Associated Central Nervous System Disease in Patients Admitted at the Douala General Hospital between 2004 and 2009: A Retrospective Study.

Authors:  Henry Namme Luma; Benjamin Clet Nguenkam Tchaleu; Elvis Temfack; Marie Solange Doualla; Daniela Pamela Ntchankam Ndenga; Yacouba Njankouo Mapoure; Alfred Kinyuy Njamnshi; Vincent-de-Paul Djientcheu
Journal:  AIDS Res Treat       Date:  2013-02-26

Review 8.  Strategies to reduce mortality and morbidity due to AIDS-related cryptococcal meningitis in Latin America.

Authors:  Jose E Vidal; Augusto C Penalva de Oliveira; Rafi F Dauar; David R Boulware
Journal:  Braz J Infect Dis       Date:  2013-05-10       Impact factor: 1.949

9.  BK virus associated meningoencephalitis in an AIDS patient treated with HAART.

Authors:  José E Vidal; Maria C Fink; Filiberto Cedeno-Laurent; Serena Delbue; Pasquale Ferrante; Rafi F Dauar; Francisco Bonasser Filho; Roberta Schiavon Nogueira; Eduardo E Calore; Claudio S Pannuti; J Roberto Trujillo; Augusto C Penalva de Oliveira
Journal:  AIDS Res Ther       Date:  2007-06-08       Impact factor: 2.250

10.  Factors influencing cerebrospinal fluid and plasma HIV-1 RNA detection rate in patients with and without opportunistic neurological disease during the HAART era.

Authors:  Paulo P Christo; Dirceu B Greco; Agdemir W Aleixo; Jose A Livramento
Journal:  BMC Infect Dis       Date:  2007-12-21       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.